Atlas Trials

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Clinical trial NCT06126341 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06126341
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2023-11-03
Primary completion
2029-05-03
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.